Jin Rong Jie·2025-08-20 18:34Group 1 - The stock price of Fosun Pharma on August 20 was 28.10 yuan, down 0.25% from the previous trading day, with a trading volume of 946 million yuan and a turnover rate of 1.60% [1] - Fosun Pharma is a comprehensive pharmaceutical enterprise engaged in research, manufacturing, and sales, covering areas such as pharmaceuticals, medical devices, diagnostics, and medical services [1] - The company continuously enriches its innovative product pipeline through various methods including independent research and development, collaborative development, and licensing [1] Group 2 - Fosun Pharma's wholly-owned subsidiary recently established Shenzhen Hengtai Biotechnology Co., Ltd. in collaboration with Shenzhen Pengfu Biomedical Industry Private Equity Investment Fund, with a registered capital of 20 million yuan [1] - The new company's business scope includes drug production and entrusted drug production [1] Group 3 - On August 20, the net outflow of main funds was 81.84 million yuan, with a cumulative net outflow of 183 million yuan over the past five days [2]